Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
SEC Accession No. 0001140361-22-019614
Filing Date
2022-05-17
Accepted
2022-05-17 16:30:36
Documents
1
Period of Report
2022-03-31
Effectiveness Date
2022-05-17

Document Format Files

Seq Description Document Type Size
1 NT 10-Q brhc10037838_nt10q.htm NT 10-Q 23487
  Complete submission text file 0001140361-22-019614.txt   24860
Mailing Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220
Business Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220 (212) 582-1199
Brooklyn ImmunoTherapeutics, Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: NT 10-Q | Act: 34 | File No.: 001-11460 | Film No.: 22934971
SIC: 2834 Pharmaceutical Preparations